These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19996843)

  • 1. Epstein Barré virus-negative diffuse large B-cell lymphoma in an HIV-infected man with a durable complete remission on highly active antiretroviral therapy alone.
    Koszyk-Szewczyk A; Bayerl M; Zurlo J; Drabick JJ
    South Med J; 2010 Jan; 103(1):76-80. PubMed ID: 19996843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage IV advanced diffuse large B-cell lymphoma in human immunodeficiency virus infection with achieving cure by using highly active antiretroviral therapy alone: a case report.
    Lim DH; Rhee JY; Park KW
    Int J STD AIDS; 2017 Aug; 28(9):932-936. PubMed ID: 28094666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term remission of HIV-associated primary CNS lymphoma achieved with highly active antiretroviral therapy alone.
    Travi G; Ferreri AJ; Cinque P; Gerevini S; Ponzoni M; Terreni MR; Lazzarin A; Crippa F
    J Clin Oncol; 2012 Apr; 30(10):e119-21. PubMed ID: 22355047
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
    Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term complete regression of nodal marginal zone lymphoma transformed into diffuse large B-cell lymphoma with highly active antiretroviral therapy alone in human immunodeficiency virus infection.
    Baraboutis IG; Marinos L; Lekakis LJ; Papastamopoulos V; Georgiou O; Tsagalou EP; Rondogianni P; Apostolidis J; Papadaki T; Skoutelis AT
    Am J Med Sci; 2009 Dec; 338(6):517-21. PubMed ID: 20010159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in blood B cell phenotypes and Epstein-Barr virus load in chronically human immunodeficiency virus–infected patients before and after antiretroviral therapy.
    Richard Y; Amiel C; Jeantils V; Mestivier D; Portier A; Dhello G; Feuillard J; Creidy R; Nicolas JC; Raphael M
    J Infect Dis; 2010 Nov; 202(9):1424-34. PubMed ID: 20874514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous Regression of Refractory Diffuse Large B-Cell Lymphoma with Improvement in Immune Status with ART in a Patient with HIV: A Case Report and Literature Review.
    Birendra KC; Afzal MZ; Wentland KA; Hashmi H; Singh S; Ivan E; Lakhani N
    Am J Case Rep; 2015 Jun; 16():347-52. PubMed ID: 26046822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy.
    Simonelli C; Tedeschi R; Gloghini A; Bortolin MT; Spina M; Bidoli E; Cinelli R; De Paoli P; Carbone A; Tirelli U
    Clin Infect Dis; 2005 Apr; 40(7):1022-7. PubMed ID: 15824995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in Epstein-Barr virus-positive AIDS-related lymphoma in the era of highly active antiretroviral therapy.
    Hishima T; Oyaizu N; Fujii T; Tachikawa N; Ajisawa A; Negishi M; Nakamura T; Iwamoto A; Hayashi Y; Matsubara D; Sasao Y; Kimura S; Kikuchi Y; Teruya K; Yasuoka A; Oka S; Saito K; Mori S; Funata N; Sata T; Katano H
    Microbes Infect; 2006 Apr; 8(5):1301-7. PubMed ID: 16697236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy.
    Nasta SD; Carrum GM; Shahab I; Hanania NA; Udden MM
    Leuk Lymphoma; 2002 Feb; 43(2):423-6. PubMed ID: 11999580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
    Gabarre J; Marcelin AG; Azar N; Choquet S; Lévy V; Lévy Y; Tubiana R; Charlotte F; Norol F; Calvez V; Spina M; Vernant JP; Autran B; Leblond V
    Haematologica; 2004 Sep; 89(9):1100-8. PubMed ID: 15377471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy.
    Navarro JT; Lloveras N; Ribera JM; Oriol A; Mate JL; Feliu E
    Haematologica; 2005 May; 90(5):704-6. PubMed ID: 15921395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era.
    Morton LM; Kim CJ; Weiss LM; Bhatia K; Cockburn M; Hawes D; Wang SS; Chang C; Altekruse SF; Engels EA; Cozen W
    Leuk Lymphoma; 2014 Mar; 55(3):551-7. PubMed ID: 23772639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of CHOP for treatment of diffuse large B-cell lymphoma with different combination antiretroviral therapy regimens: SCULPT study.
    Wong AY; Marcotte S; Laroche M; Sheehan NL; Kukreti V; Routy JP; Lemieux B; Seki JT; Rouleau D; Tseng A
    Antivir Ther; 2013; 18(5):699-707. PubMed ID: 23640963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
    Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
    J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
    Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
    Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment with autologous peripheral blood stem cell transplantation for acquired immunodeficiency syndrome (AIDS)-related malignant lymphoma.
    NAGAI Y; MORI M; INOUE D; KIMURA T; SHIMOJI S; TOGAMI K; TABATA S; MATSUSHITA A; NAGAI K; Imai Y; Takafuta T; Takahashi T
    Rinsho Ketsueki; 2009 Nov; 50(11):1641-6. PubMed ID: 20009441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.